Access Statistics for Bruno Versaevel

Author contact details at EconPapers.

Working Paper File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 1 1 1 16
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 0 0 1 10
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 1 1 1 14
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 0 0 1 28
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 1 1 2 12
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 0 0 0 0 12
Approche économique des accords de report d’entrée dans l’industrie pharmaceutique 0 0 0 0 0 0 1 1
Better than a compromise, a third way: Using patent pooling to accelerate access to vaccines and treatments against Covid-19 0 0 0 1 0 0 1 5
Better than a compromise, a third way: patent pool to accelerate access to vaccines and treatments against Covid-19 0 0 0 1 0 0 2 7
Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain? 0 0 3 13 0 1 5 22
Biopharmaceutical R&D outsourcing: Short-term gain for long-term pain? 0 0 0 0 0 0 4 6
Caveat Preemptor: Coordination Failure and Success in a Duopoly Investment Game 0 0 0 0 0 0 1 37
Conflict and Cooperation on R&D Markets 0 0 0 90 0 0 2 284
Coordination and Cooperation in Investment Timing with Externalities? 0 0 0 17 2 2 3 104
Covid-19: Should intellectual property rights be challenged? 0 0 0 8 1 2 3 76
Dynamic competition and intellectual property rights in a model of product development 0 0 0 0 0 0 0 18
Dynamic competition and intellectual property rights in a model of product development 0 0 1 1 2 2 3 38
Dynamique des marchés et ajustement de la protection Intellectuelle 0 0 0 0 1 1 2 15
Dynamique des marchés et ajustement de la protection intellectuelle 0 0 0 0 0 0 1 9
Développements récents de l'approche économique des sanctions dans le cas des cartels 0 0 0 0 0 0 0 28
Développements récents de l'approche économique des sanctions dans le cas des cartels 0 0 0 0 0 0 3 9
Développements récents de l'approche économique des sanctions dans le cas des cartels 0 0 0 0 0 0 1 18
From Private to Public Common Agency 0 0 0 0 0 0 1 41
From private to public common agency 0 0 0 0 0 0 2 9
Horizontal R&D Cooperation and Spillovers: Evidence from France 0 0 0 0 0 0 1 8
Implications des licences FRAND pour la concurrence: un regard économique 0 0 0 0 0 0 1 9
Implications des licences FRAND pour la concurrence: un regard économique 0 0 0 0 0 0 1 16
Innovation and Imitation Incentives in Dynamic Duopoly 0 0 0 0 0 0 0 31
Innovation and Imitation Incentives in Dynamic Duopoly 0 0 0 0 0 0 1 31
Innovation and imitation incentives in dynamic duopoly 0 0 0 49 1 1 3 96
Investment Timing and Vertical Relationships 0 0 0 37 0 0 1 90
Investment timing and vertical relationships 0 0 0 0 0 0 0 8
Market Share, R&D Cooperation, and EU Competition Policy 0 0 2 3 0 0 3 28
Market shares, R&D agreements, and the EU block exemption 0 0 0 0 0 0 3 15
Market shares, R&D agreements, and the EU block exemption 0 0 0 0 0 1 3 33
Mise en oeuvre de la collusion et détection: approches actives et passives 0 0 0 0 0 0 0 14
Mise en oeuvre de la collusion et détection: approches actives et passives 0 0 0 0 0 0 0 3
On the Optimal Timing of Innovation and Imitation 0 0 0 0 0 0 0 16
On the Timing of Vertical Relationships 0 0 0 45 1 2 2 82
On the tacit collusion equilibria of a dynamic duopoly investment game 0 0 0 0 0 0 0 10
On the timing of innovation and imitation 0 0 0 28 0 0 1 43
On the timing of innovation and imitation in dynamic duopoly 0 0 0 0 0 0 0 10
On the timing of vertical relationships 0 0 0 36 0 0 1 70
One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry 0 0 0 0 0 1 3 30
One Lab, Two Firms, Many Possibilities: on R&D outsourcing in the biopharmaceutical industry 0 0 1 28 1 1 4 60
One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry 0 0 0 0 0 0 2 11
One lab, two firms, many Possibilities: On R&D outsourcing in the biopharmaceutical industry 0 0 0 0 0 0 1 13
Optimal Collusion with Limited Liability 0 0 0 0 0 0 2 35
Optimal Collusion with Limited Liability and Policy Implications 0 0 0 52 0 0 1 119
Optimal Collusion with Limited Liability and Policy Implications 0 0 0 0 0 0 0 22
Optimal collusion with limited liability 0 0 0 40 0 0 2 89
Patent Pools and Dynamic R&D Incentives 0 0 0 0 0 0 0 22
Patent Pools and R&D Dynamics 0 0 0 0 0 1 1 25
Patent pools and dynamic R&D incentives 0 0 0 0 0 0 1 42
Pool patents to get COVID vaccines and drugs to all 0 0 0 7 0 0 0 33
Quel rôle pour la part de marché quand le droit de la concurrence porte son regard sur la coopération et l'innovation 0 0 0 0 0 0 0 11
Quel rôle pour un critère de part de marché dans la réglementation de la coopération en recherche et développement ? 0 0 0 0 1 1 3 9
Quelles spécificités des accords de distribution en ligne ? 0 0 0 0 0 0 2 9
R&D Delegation in a Duopoly with Spillovers 0 0 0 0 0 0 0 1
R&D Delegation in a Duopoly with Spillovers 0 0 0 0 0 0 0 12
Tacit Collusion in Investment Timing 0 0 0 0 0 0 0 16
Testing Optimal Punishment Mechanisms under Price Regulation: the Case of the Retail Market for Gasoline 0 0 0 47 1 1 4 251
Testing Optimal Punishment Mechanisms under Price Regulation: the Case of the Retail Market for Gasoline 0 0 0 32 0 0 2 133
Testing Optimal Punishment Mechanisms under Price Regulation: the Case of the Retail Market for Gasoline 0 0 0 47 0 1 3 245
Timing Vertical Relationships 0 0 0 53 0 0 0 72
Timing Vertical Relationships 0 0 0 0 0 0 2 24
Timing Vertical Relationships 0 0 0 0 0 0 1 16
Timing Vertical Relationships 0 0 0 0 1 1 1 22
Timing Vertical Relationships 0 0 0 0 0 0 0 20
Timing Vertical Relationships 0 0 0 0 0 0 0 25
When should a winner take all, or pay some? Innovation and imitation incentives in a dynamic duopoly 0 0 0 77 1 2 3 56
Total Working Papers 0 0 7 712 16 24 100 2,855
3 registered items for which data could not be found


Journal Article File Downloads Abstract Views
Last month 3 months 12 months Total Last month 3 months 12 months Total
Alertness, Leadership, and Nascent Market Dynamics 0 0 0 2 1 2 3 39
Caveat preemptor: Coordination failure and success in a duopoly investment game 0 0 0 11 0 1 5 108
Co-ordination costs and vertical integration in production franchise networks: a common agency model 0 0 0 46 0 1 2 137
Dynamic competition and intellectual property rights in a model of product development 0 0 0 7 1 3 6 80
From private to public common agency 0 0 1 29 0 0 1 118
Horizontal R and D cooperation and spillovers: evidence from France 0 0 0 5 0 0 1 42
Investment timing and vertical relationships 0 0 0 16 1 2 3 48
La spéculation sur le marché des actions: un phénomène monétaire ? 0 0 0 1 0 1 1 19
Market shares, R&D agreements, and the EU block exemption 0 0 0 11 0 0 1 81
Mieux qu’un compromis, une troisième voie: le panier de brevets pour accélérer l’accès aux vaccins et traitements contre la COVID-19 0 0 0 5 0 1 2 12
On the tacit collusion equilibria of a dynamic duopoly investment game 0 0 0 12 0 1 2 78
One lab, two firms, many possibilities: On R&D outsourcing in the biopharmaceutical industry 0 0 0 2 2 5 10 46
Optimal collusion with limited liability 0 0 0 9 1 1 1 65
Patent pools and dynamic R&D incentives 0 0 0 27 0 1 4 115
Pool patents to get COVID vaccines and drugs to all 0 0 0 3 0 0 3 11
R&D Delegation in a Duopoly with Spillovers 1 1 1 26 1 1 2 109
Total Journal Articles 1 1 2 212 7 20 47 1,108


Statistics updated 2025-09-05